Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients’ walking abilities and muscle strength are examined on a regular basis, doctors have yet to determine when the lower limb muscles begin to deteriorate…
More: continued here
Filed under: Multiple Sclerosis on January 30th, 2012 | No Comments »
Rebif® (interferon beta-1a), a disease-modifying medication used to treat relapsing forms of multiple Sclerosis (MS), is now available in the UK to treat individuals with clinically isolated syndrome (CIS), a potential early indicator of MS, announced Merck Serono, a division of Merck KGaA, Darmstadt, Germany…
More: continued here
Filed under: Multiple Sclerosis on January 26th, 2012 | No Comments »
For the first time ever, stem cells from umbilical cords have been converted into other types of cells, which may eventually lead to new treatment options for spinal cord injuries and multiple sclerosis, among other nervous system diseases…
More: continued here
Filed under: Multiple Sclerosis on January 23rd, 2012 | No Comments »
Neuroscientists at Kessler Foundation have documented increased cerebral activation in patients with multiple sclerosis (MS) following memory retraining using the modified Story Memory Technique (mSMT)…
More: continued here
Filed under: Multiple Sclerosis on January 23rd, 2012 | No Comments »
New research highlights the possibility of reversing ageing in the central nervous system for multiple sclerosis (MS) patients. The study is published in the journal Cell Stem Cell. As we get older, our bodies’ ability to regenerate decreases…
More: continued here
Filed under: Multiple Sclerosis on January 10th, 2012 | No Comments »
A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS…
More: continued here
Filed under: Multiple Sclerosis on January 9th, 2012 | No Comments »
Radiology researchers at The University of Texas Health Science Center at Houston (UTHealth) have found evidence that multiple sclerosis affects an area of the brain that controls cognitive, sensory and motor functioning apart from the disabling damage caused by the disease’s visible lesions…
More: continued here
Filed under: Multiple Sclerosis on January 3rd, 2012 | No Comments »
Working together, researchers at Cleveland Clinic and Mayo Clinic have for the first time examined early multiple sclerosis (MS) brain lesions in the cerebral cortex. These lesions are thought to be critical to MS progression and the researchers found that the lesions are distinctly different than previously speculated, giving clues to better disease management…
More: […]
Filed under: Multiple Sclerosis on December 9th, 2011 | No Comments »
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS)…
More: continued here
Filed under: Multiple Sclerosis on December 8th, 2011 | No Comments »
Multiple sclerosis (MS) may progress from the outermost layers of the brain to its deep parts, and isn’t always an “inside-out” process as previously thought, reported a new collaborative study from researchers at the Mayo Clinic and the Cleveland Clinic…
More: continued here
Filed under: Multiple Sclerosis on December 8th, 2011 | No Comments »